Form 4: Roy Blunt Receives Restricted Stock Units from Tenet

Director Roy Blunt was granted 1,188 restricted stock units by Tenet Healthcare Corp as part of the company's stock incentive plan.

Summary

• Director Roy Blunt received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare Corp common stock.
• The units are scheduled to vest on May 27, 2027, which is the first anniversary of the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant market-moving implications.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the granted units is subject to future fluctuations in Tenet Healthcare Corp's common stock price.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director will receive shares or a cash equivalent for up to 37% of the award.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure long-term alignment between leadership and shareholder interests in the healthcare sector.

Comparison to Industry Standards

• The use of restricted stock units as a component of director compensation is consistent with standard practices among large-cap healthcare companies.
• The one-year vesting period is a common retention and alignment mechanism for board-level equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation grant.

Next Steps

• Vesting of the 1,188 restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction